NASDAQ$HQY

HealthEquity Inc · Q4 2026 earnings

Q4 2026 earnings · · After market close · Investor relations

Briefing

HealthEquity reported Q4 fiscal 2026 revenue with net income of $49.7M ($0.58 diluted EPS, non-GAAP $0.95).

For the quarter ended January 31, 2026, net income rose to $49.7M (15% margin) from $26.4M; diluted EPS was $0.58 and non-GAAP EPS $0.95 (+38%). Fiscal 2026 net income was $215.2M ($2.46 GAAP EPS, $4.00 non-GAAP EPS) on strong HSA platform growth. Management guided fiscal 2027 revenue of $1.405–1.415B and non-GAAP EPS of $4.56–4.65.

  • Q4 net income $49.7M; margin 15% vs 8% prior year.
  • Q4 GAAP EPS $0.58; non-GAAP EPS $0.95 (+38%).
  • FY2026 net income $215.2M (+89% YoY).
  • FY2026 non-GAAP EPS $4.00 vs $3.12 prior year.
  • FY2027 revenue guide $1.405–1.415B.

Headline financials

EPS (adj)

$0.95

Previous: $0.69+37.7%
Net Income

$49.7M

Previous: $26.4M+88.5%

Revenue & EPS history

HealthEquity · Revenue · Quarterly

$355M

Q1 2027+7.2%vs Q1 2026
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

HealthEquity · $249M total across 3 segments · Q3 2024

  • Service Revenue
    $108M-1.0%
  • Custodial Revenue
    $107M+42.8%
  • Interchange Revenue
    $35.1M+6.9%

Forward guidance

For fiscal 2027 ending January 31, 2027, HealthEquity expects revenue of $1.405–1.415B, GAAP net income $239–246M ($2.78–2.85 EPS), non-GAAP net income $392–400M ($4.56–4.65 EPS), and Adjusted EBITDA $618–628M.

Tailwinds

  • FY2027 non-GAAP EPS guide $4.56–4.65.
  • Adjusted EBITDA guide $618–628M.
  • Net income margin expansion in Q4 and FY2026.
  • HSA ecosystem scale driving operating leverage.

Headwinds

  • Rate-sensitive float income could moderate.
  • Competitive pressure in health-benefits technology.
  • Regulatory changes to tax-advantaged accounts a risk.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2026

Historical avgQ4 2026

-0.4%

Avg return

Earnings day

-2.0%

Avg return

5 days after

-1.1%

Avg return

30 days after

54%

29 / 54 earnings

Positive

+10.8%

Q1 2024

Best reaction

-22.2%

Q4 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2027-2.8%-5.8%
Q4 2026+0.7%+2.8%+8.4%
Q3 2026-2.9%-5.5%-7.7%
Q2 2026+7.6%+4.7%-0.3%
Q1 2026+9.1%+7.1%-1.5%
Q4 2025-17.1%-11.2%-16.9%
Q3 2025-4.8%-4.6%-0.5%
Q2 2025+3.9%-4.2%-1.7%
Q1 2025+2.1%+4.4%+2.3%
Q4 2024-1.9%-4.0%-3.7%
Q3 2024+0.4%-0.8%-0.7%
Q2 2024+4.4%+2.4%+9.4%
Q1 2024+10.8%+9.4%+6.1%
Q4 2023+0.8%-1.1%+0.7%
Q3 2023-2.3%-7.7%-9.8%
Q2 2023+0.1%+4.6%+5.5%
Q1 2023+2.0%-0.0%-4.8%
Q4 2022+2.4%+11.3%+20.3%
Q3 2022-21.3%-24.8%-14.4%
Q2 2022+1.2%-1.4%-0.8%
Q1 2022+0.4%-3.2%-1.6%
Q4 2021-5.9%-9.4%-11.8%
Q3 2021-3.7%-8.5%+8.1%
Q2 2021+5.4%-11.8%-6.2%
Q1 2021-6.6%+5.9%-5.6%
Q4 2020-22.2%-17.9%-15.1%
Q3 2020+2.9%+9.6%+17.4%
Q2 2020-6.1%-6.3%-8.1%
Q1 2020+1.7%+6.0%-0.4%
Q4 2019+2.9%-10.2%-23.8%
Q3 2019-17.5%-23.8%-38.8%
Q2 2019+2.9%+3.0%-3.9%
Q1 2019+4.8%+4.6%+1.1%
Q4 2018+8.7%+6.7%+11.3%
Q3 2018-5.8%-6.4%-1.7%
Q2 2018+7.3%+6.0%+23.1%
Q1 2018+8.8%+7.4%-0.2%
Q4 2017-4.6%-12.1%-0.9%
Q3 2017-1.1%-2.4%-2.8%
Q2 2017+3.0%-0.7%+13.1%
Q1 2017+7.9%+7.4%+11.7%
Q4 2016+5.2%
Q3 2016-4.6%
Q2 2016+6.5%
Q1 2015-0.1%
Q1 2016+3.2%
Q4 2013-0.1%
Q1 2014-0.1%
Q4 2015-1.0%
Q3 2014-8.0%
Q3 2015+0.7%
Q2 2015-0.3%
Q4 2014-0.3%
Q2 2014-0.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro